Home LiteratureArticle Details
PMID: 15735761 Published · ppublish English Journal Article

Tweak induces mammary epithelial branching morphogenesis.

Oncogene ·Vol. 24 ·No. 16 ·2005-04-14 ·Pages 2613-24

Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, Wang MZ, Hsu YM, Burkly LC

Abstract

Members of the tumor necrosis factor (TNF) superfamily regulate cell survival and proliferation and have been implicated in cancer. Tweak (TNF-related weak inducer of apoptosis) has pleiotropic biological functions including proapoptotic, proangiogenic and proinflammatory activities. We explored a role for Tweak in mammary gland transformation using a three-dimensional model culture system. Tweak stimulates a branching morphogenic phenotype, similar to that induced by pro-oncogenic factors, in Eph4 mammary epithelial cells cultured in matrigel. Increased proliferation and invasiveness are observed, with a concomitant inhibition of functional differentiation. Levels of matrix metalloproteinase-9 (MMP-9) are significantly increased following Tweak treatment. Notably, MMP inhibitors are sufficient to block the branching phenotype induced by Tweak. The capacity to promote proliferation, inhibit differentiation and induce invasion suggests a role for Tweak in mammary gland tumorigenesis. Consistent with this, we have observed elevated protein levels of the Tweak receptor, Fn14, in human breast tumor cell lines and xenograft models as well as in primary human breast tumors. Together, our results suggest that the Tweak/Fn14 pathway may be protumorigenic in human breast cancer.

MeSH Terms
Apoptosis Regulatory Proteins Breast Neoplasms/metabolism Carrier Proteins/metabolism,physiology Cell Culture Techniques Cell Differentiation Cell Line, Tumor Cell Proliferation Collagen Cytokine TWEAK Drug Combinations Epithelial Cells/metabolism Humans Immunohistochemistry Laminin Mammary Glands, Human/cytology Matrix Metalloproteinase 9/metabolism Models, Biological Morphogenesis Proteoglycans Receptors, Tumor Necrosis Factor/metabolism TWEAK Receptor Tumor Necrosis Factors
Chemicals
Apoptosis Regulatory Proteins Carrier Proteins Cytokine TWEAK Drug Combinations Laminin Proteoglycans Receptors, Tumor Necrosis Factor TNFRSF12A protein, human TNFSF12 protein, human TWEAK Receptor Tumor Necrosis Factors matrigel Collagen Matrix Metalloproteinase 9
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Michaelson Jennifer S
Department of Exploratory Science, Biogen Idec, 12 Cambridge Center, Bio6-320, Cambridge MA, USA. [email protected]
Cho Sandy
Browning Beth
Zheng Timothy S
Lincecum John M
Wang Monica Z
Hsu Yen-Ming
Burkly Linda C
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2005-04-14
Pages
2613-24
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]